Integramed America, Inc. (INMD) Reports In-Line Q2 EPS
Integramed America, Inc. (NASDAQ: INMD) reported Q2 adjusted EPS of $0.12, in-line with the analyst estimate of $0.12. Revenue for the quarter came in at $69.05 million versus the consensus estimate of $68.55 million.